期刊文献+

奥沙利铂与胰岛素在葡萄糖注射液中配伍稳定性的考察 被引量:9

Stability of Oxaliplatin and Insulin for Injection in Compatibility Solutions
下载PDF
导出
摘要 目的:考察在葡萄糖溶液中,奥沙利铂和胰岛素配伍的稳定性。方法:观察及测定两种注射剂在5%葡萄糖注射液中配伍后于室温放置24 h内外观、pH及不溶性微粒,并采用HPLC法分别测定配伍液中奥沙利铂与胰岛素的含量。结果:配伍液在室温24 h内无变色、气体、沉淀、浑浊等发生,微粒数、pH等无明显变化,奥沙利铂、胰岛素的含量也无明显变化。结论:在实验条件下,奥沙利铂与胰岛素注射液在5%的葡萄糖注射液中配伍24 h内稳定。 Objective: To observe the compatibility of oxalipiatin and insulin for injection. Method: The changes in appearance, particles and pH of the mixture of 5% glucose injection within 24 h at ambient temperature were observed. The concentrations of the ox- aliplatin and insulin were determined by HPLC. Result: There was no evident changes in appearance, no color, gas, precipitation or turbid generated. Also there was no changes in croparticle,pH and the content of oxaliplatin and insulin within 24 h. Conclusion: Insulin injection mixing with oxaliplatin for injection in GS of 5% was stabile within 24h.
出处 《中国药师》 CAS 2010年第9期1307-1309,共3页 China Pharmacist
关键词 高效液相色谱法 胰岛素 奥沙利铂 配伍 稳定性 HPLC Insulin Oxaliplatin Compatibility Stability
  • 相关文献

参考文献4

二级参考文献59

  • 1张文,许立功.晚期结直肠癌的化疗进展[J].中国癌症杂志,2004,14(4):378-382. 被引量:25
  • 2朱延勤,严汉英,刘学丽,潘伟娜,王珂.RP-HPLC测定胰岛素滴眼液的含量[J].中国药学杂志,1995,30(7):432-433. 被引量:5
  • 3[3]Missct JL.Oxaliolatinin practice[J].Br J Cancer,1998,77(Suppl 4):S4~S7.
  • 4胡绍文,实用糖尿病学,1998年,100页
  • 5朱延琴,中国药学杂志,1995年,30卷,432页
  • 6中华人民共和国卫生部药典编委会,中华人民共和国药典.二部,1995年,753页
  • 7Johnson I S.Science[J].1983,219:632.
  • 8Kowarski C R,Bado B,Shah S,Kowarski D,Kowarski A A.J.Pharm.Sci.[J].1983,72(6):692.
  • 9Yalow R S,Berson S A.Nature[J].1959,184:1648.
  • 10Cheyenne D,Trivin F,Porquet D.Diabetes Metab.[J].1999,25:459.

共引文献418

同被引文献97

  • 1陈碧.HPLC法测定人血清中5-氟尿嘧啶浓度[J].药学进展,2005,29(7):332-334. 被引量:8
  • 2黄淑萍,王倩,张洁,徐雯蕊.反相高效液相色谱法测定氟脲苷的血药浓度[J].天津药学,2006,18(3):24-25. 被引量:1
  • 3刘祝东,栾春芳,普绍平.奥沙利铂及其手性异构体的高效液相色谱分析[J].贵金属,2007,28(2):49-52. 被引量:8
  • 4中国药典[S].2010年版.二部.附录ⅨJ.
  • 5Barberi-Heyob M, Merlin JL, Weber B. Determination of 5-Fluoroura- cil and its main metabolites in plasma by high-performance liquid chromatography[J]. J Chromatography,1992,573:247-252.
  • 6Joulia JM, Pinguet F, Grosse PY, et al. Determination of 5-Fluorouracil and its main metabolites in plasma by high-performance liquidchroma- tography:application to a pharmacokinetic study [ J ]. J Chromatogra- phy B. 1997.692:427.
  • 7Jung M, Berger G, Pohlen U, et al. Simultaneous determination of 5- Fluorouracil and its active metabolites in serum and tissue by high- performance liquid chromatography[J]. J Chromatography B,1997, 702 : 193-202.
  • 8Luo F R, Yen T Y, Wyrick S D, et al. High - performance liquid chromatographic separation of the biotransformation products of oxaliplatin[J]. J Chromatogr B, 1999, 724(2) : 345.
  • 9Koellensperger G, Harm S. Ultra - fast HPLC ICP- MS analysis of oxaliplatin in patient urine[J]. Anal Bioanal Chem 2010, 397(3): 401.
  • 10Mowaka S, Linscheid M. Separation and characterization of oxaliplatin dinucleotides from DNA using HPLC - ESI ion trap mass spectrometry[J]. Anal Bioanal Chem, 2008, 392 (5): 819.

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部